Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
1.720
+0.060 (3.61%)
Oct 8, 2025, 10:07 AM EDT - Market open
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $53.30 million as of October 8, 2025. Its market cap has decreased by -44.07% in one year.
Market Cap
53.30M
Enterprise Value
3.22M
1-Year Change
-44.07%
Ranking
Category
Stock Price
$1.72
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $53.30M, a decrease of -85.03%. That is a compound annual growth rate of -72.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 51.40M | -40.16% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |